These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 9232339
1. Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Taioli E, Garbers S, Bradlow HL, Carmella SG, Akerkar S, Hecht SS. Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):517-22. PubMed ID: 9232339 [Abstract] [Full Text] [Related]
2. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Hecht SS, Chung FL, Richie JP, Akerkar SA, Borukhova A, Skowronski L, Carmella SG. Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661 [Abstract] [Full Text] [Related]
7. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine. Carmella SG, Ye M, Upadhyaya P, Hecht SS. Cancer Res; 1999 Aug 01; 59(15):3602-5. PubMed ID: 10446969 [Abstract] [Full Text] [Related]
9. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer. Biomarkers; 2000 Aug 01; 5(1):33-45. PubMed ID: 23885904 [Abstract] [Full Text] [Related]
10. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS. Cancer Epidemiol Biomarkers Prev; 1996 Jul 01; 5(7):521-5. PubMed ID: 8827356 [Abstract] [Full Text] [Related]
11. Inhibitory effects of 6-phenylhexyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation and lung tumorigenesis in rats. Hecht SS, Trushin N, Rigotty J, Carmella SG, Borukhova A, Akerkar S, Desai D, Amin S, Rivenson A. Carcinogenesis; 1996 Sep 01; 17(9):2061-7. PubMed ID: 8824535 [Abstract] [Full Text] [Related]
12. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats. Leslie EM, Ghibellini G, Nezasa K, Brouwer KL. Carcinogenesis; 2007 Dec 01; 28(12):2650-6. PubMed ID: 17724374 [Abstract] [Full Text] [Related]
13. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK. Cancer Res; 2002 Jan 01; 62(1):129-34. PubMed ID: 11782369 [Abstract] [Full Text] [Related]
14. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS. J Natl Cancer Inst; 2001 Mar 07; 93(5):378-81. PubMed ID: 11238699 [Abstract] [Full Text] [Related]
15. [Detection of metabolites of tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung cancer smokers' urine]. Zhang T, Lai B, Duan L, Wang X. Zhongguo Fei Ai Za Zhi; 2006 Jun 20; 9(3):231-5. PubMed ID: 21172151 [Abstract] [Full Text] [Related]
16. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Kassie F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, Hecht SS. Cancer Res; 2007 Jul 01; 67(13):6502-11. PubMed ID: 17616712 [Abstract] [Full Text] [Related]
17. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Murphy SE, Carmella SG, Idris AM, Hoffmann D. Cancer Epidemiol Biomarkers Prev; 1994 Jul 01; 3(5):423-8. PubMed ID: 7920210 [Abstract] [Full Text] [Related]
18. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Richie JP, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Cancer Epidemiol Biomarkers Prev; 1997 Oct 01; 6(10):783-90. PubMed ID: 9332760 [Abstract] [Full Text] [Related]
19. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Carmella SG, Le Ka KA, Upadhyaya P, Hecht SS. Chem Res Toxicol; 2002 Apr 01; 15(4):545-50. PubMed ID: 11952341 [Abstract] [Full Text] [Related]
20. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Wiener D, Doerge DR, Fang JL, Upadhyaya P, Lazarus P. Drug Metab Dispos; 2004 Jan 01; 32(1):72-9. PubMed ID: 14709623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]